JJ
Jean Jacques Bienaime
DELAYED 1 MONTH
Director
Ascendis Pharma A/S
Immunome Inc.
INCYTE CORP
Keros Therapeutics, Inc.
Filings
10
Companies
4
Latest
Jun 8, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
53
IMNM+32% IN
Immunome Inc.
Jean Jacques Bienaime
Director
Purchase
$204.3K
10,500 sh
Jun 9 9:40 PM
Jun 5, 2026
49
Keros Therapeutics, Inc.
Jean Jacques Bienaime
Director
Purchase
$10.6K
1,000 sh
May 19 8:15 PM
May 15, 2026
49
KROS+37% IN
Keros Therapeutics, Inc.
Jean Jacques Bienaime
Director
Purchase
$22.4K
2,000 sh
Mar 11 8:33 PM
Mar 9, 2026